JCCG-TOP2: Evaluating the Feasibility and Clinical Utility of Comprehensive Genomic Profiling in Pediatric Solid Tumors

被引：0
|
作者：
Tao, Kayoko [1 ,2 ]
Yoshioka, Takako [3 ]
Kato, Miho [4 ]
Kubo, Takashi [2 ]
Kohsaka, Shinji [5 ]
Yatabe, Yasushi [6 ]
Takimoto, Tetsuya [4 ]
Ichimura, Koichi [7 ,8 ]
Mochizuki, Shinji
Shichino, Hiroyuki [9 ]
Aburatani, Hiroyuki [10 ]
Ogawa, Chitose [1 ]
Suzuki, Tatsuya [11 ]
Matsumoto, Kimikazu [12 ]
Ichikawa, Hitoshi [2 ]
Kato, Motohiro [12 ,13 ]
机构：
[1] Natl Canc Ctr, Dept Pediat Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Clin Genom, Tokyo, Japan
[3] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan
[4] Natl Ctr Child Hlth & Dev, Dept Childhood Canc Data Management, Tokyo, Japan
[5] Natl Canc Ctr, Div Cell Signaling, Tokyo, Japan
[6] Natl Canc Ctr, Dept Diagnost Pathol, Tokyo, Japan
[7] Juntendo Univ, Dept Brain Dis Transl Res, Bunkyo City, Japan
[8] Natl Canc Ctr, Div Brain Tumor Transl Res, Tokyo, Japan
[9] Natl Ctr Global Hlth & Med, Dept Pediat, Shinjuku City, Japan
[10] Univ Tokyo, Genome Sci, RCAST, Tokyo, Japan
[11] Natl Canc Ctr, Dept Hematol, Tokyo, Japan
[12] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan
[13] Univ Tokyo Hosp, Dept Pediat, Tokyo, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-2002
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [41] Clinical utility of comprehensive genomic profiling for patients with cancer of unknown primary site
    Kudo, Ryo
    Kano, Yoshihito
    Noji, Rika
    Kakuta, Ryota
    Onishi, Iichiro
    Kimura, Kouichiro
    Tanimoto, Kousuke
    Miya, Fuyuki
    Mitsumura, Takahiro
    Oshima, Noriko
    Ariizumi, Yousuke
    Nakagawa, Tsuyoshi
    Ishikawa, Toshiaki
    Miyake, Satoshi
    Ikeda, Sadakatsu
    ANNALS OF ONCOLOGY, 2022, 33 : S500 - S500
  • [42] Feasibility of Comprehensive Genomic Profiling (CGP) in Real-Life Clinical Practice
    Nibid, Lorenzo
    Sabarese, Giovanna
    Righi, Daniela
    Rossi, Silvia Maria
    Merlini, Giorgia
    Crucitti, Pierfilippo
    Vincenzi, Bruno
    Tonini, Giuseppe
    Perrone, Giuseppe
    DIAGNOSTICS, 2023, 13 (04)
  • [43] Clinical application of comprehensive next-generation sequencing-based genomic profiling for identification of actionable genomic alterations in pediatric solid tumors and hematolymphoid malignancies: The Foundation Medicine pediatric experience.
    Hawryluk, Matthew J.
    Wang, Kai
    Chmielecki, Juliann
    Ali, Siraj M.
    Palmer, Gary A.
    Downing, Sean
    Curran, John
    Garcia, Lazaro
    White, Emily
    Lipson, Doron
    Yelensky, Roman
    Stephens, Philip J.
    Miller, Vincent A.
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors
    Cobain, Erin F.
    Wu, Yi-Mi
    Chugh, Rashmi
    Worden, Francis
    Smith, David C.
    Schuetze, Scott M.
    Zalupski, Mark M.
    Sahai, Vaibhav
    Alva, Ajjai
    Schott, Anne F.
    Caram, Megan E. V.
    Hayes, Daniel F.
    Stoffel, Elena M.
    Jacobs, Michelle F.
    Kumar-Sinha, Chandan
    Cao, Xuhong
    Wang, Rui
    Lucas, David
    Ning, Yu
    Rabban, Erica
    Bell, Janice
    Camelo-Piragua, Sandra
    Udager, Aaron M.
    Cieslik, Marcin
    Lonigro, Robert J.
    Kunju, Lakshmi P.
    Robinson, Dan R.
    Talpaz, Moshe
    Chinnaiyan, Arul M.
    JAMA ONCOLOGY, 2021, 7 (04) : 525 - 533
  • [45] Feasibility and clinical utility of cancer whole genome and transcriptome sequencing for pediatric and young adult solid tumors.
    Shukla, Neerav
    Levine, Max
    Gundem, Gunes
    Spitzer, Barbara
    Gutierrez-Abril, Jesus
    Bouvier, Nancy
    Ossa, Juan E. Arango
    Medina-Martinez, Juan
    Stockfisch, Emily
    O'Donohue, Tara
    Zehir, Ahmet
    Viale, Agnes
    Modak, Shakeel
    Dela Cruz, Filemon S.
    Slotkin, Emily K.
    Karajannis, Matthias A.
    Bender, Julia Lynne Glade
    Walsh, Michael Francis
    Kung, Andrew
    Papaemmanuil, Elli
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] A Retrospective Analysis of Molecular Profiling of Pediatric Solid Tumors Using OmniSeq Comprehensive
    Wiltsie, L.
    Papanicolau-Sengos, A.
    Morrison, C.
    Kelly, K.
    Barth, M.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S405 - S406
  • [47] The impact of comprehensive genomic profiling in the management of patients with metastatic solid tumors in a developing country
    Barrios, Pablo M.
    Debiasi, Marcio
    Cauduro, Carolina
    Herrmann, Fabio
    Marchese, Gabriela
    Pesenatto, Gustavo Guthmann
    Menegat, Franciele A.
    Prolla, Gabriel
    Barrios, Carlos H.
    Fay, Andre Poisl
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Comprehensive genomic profiling is effective in determining treatment decisions for advanced solid tumors patients
    Ishida, Masaki
    Iwasaku, Masahiro
    Doi, Toshifumi
    Ishikawa, Takeshi
    Yosimura, Akihiro
    Morimoto, Kenji
    Tokuda, Shinsaku
    Kim, Young Hak
    Yamada, Tadaaki
    Takayama, Koichi
    ANNALS OF ONCOLOGY, 2023, 34 : S1432 - S1432
  • [49] COMPREHENSIVE GENOMIC PROFILING APPROACHES IN EUROPE AND THE US: A REVIEW OF GUIDELINES AND RECOMMENDATIONS FOR SOLID TUMORS
    von Wilamowitz-Moellendorff, C.
    Kadambi, A.
    Farraia, M.
    Deshpande, S.
    VALUE IN HEALTH, 2023, 26 (12) : S265 - S265
  • [50] Clinical utility of next-generation sequencing (NGS)-based genomic profiling of advanced solid tumors in routine clinical practice.
    Julka, Pramod Kumar
    Nayyar, Harleen Kaur
    Hussain, Shaikmaheboob
    Mohindra, Tarun
    Verma, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345